Facing the challenges of chronic Pruritus: A report from a multidisciplinary medical itch centre in Germany

Acta Dermato-Venereologica

Volumn 95, Issue 3, 2015, Pages 266-271

  Ständer, Sonja ^a   Pogatzki Zahn, Esther ^a   Stumpf, Astrid ^a   Fritz, Fleur ^a   Pfleiderer, Bettina ^a   Ritzkat, Anika ^a   Bruland, Philipp ^a   Lotts, Tobias ^a   Müller Tidow, Carsten ^a   Heuft, Gereon ^a   Pavenstädt, Hermann Joseph ^a   Schneider, Gudrun ^a   Van Aken, Hugo ^a   Heindel, Walter ^a   Wiendl, Heinz ^a   Dugas, Martin ^a   Luger, Thomas A ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Aprepitant; Brachioradial pruritus; Competence center chronic pruritus; Itch clinics; Nerve fibre density; Neurodermatology; Prurigo nodularis; Substance P

Indexed keywords

NEUROKININ 1 RECEPTOR ANTAGONIST; ANTIPRURITIC AGENT;

ARTICLE; BASIC RESEARCH; CHRONIC DISEASE; CHRONIC PATIENT; CLINICAL RESEARCH; DATA PROCESSING; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; GERMANY; HOSPITAL PATIENT; HUMAN; MEDICAL CARE; MEDICAL DOCUMENTATION; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; PRURITUS; SELF REPORT; TRANSLATIONAL RESEARCH; COOPERATION; INTERDISCIPLINARY COMMUNICATION; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PATIENT CARE; PREDICTIVE VALUE; PROGNOSIS; PROGRAM DEVELOPMENT; RISK FACTOR; WORKFLOW;

ANTIPRURITICS; CHRONIC DISEASE; COOPERATIVE BEHAVIOR; ELECTRONIC HEALTH RECORDS; GERMANY; HUMANS; INTERDISCIPLINARY COMMUNICATION; MODELS, ORGANIZATIONAL; OUTPATIENT CLINICS, HOSPITAL; PATIENT CARE TEAM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROGRAM DEVELOPMENT; PRURITUS; RISK FACTORS; TRANSLATIONAL MEDICAL RESEARCH; WORKFLOW;

EID: 84922817153     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1949     Document Type: Article

References (60)

1. Shive M, Linos E, Berger T, Wehner M, Chren MM. Itch as a patient-reported symptom in ambulatory care visits in the United States. J Am Acad Dermatol 2013; 69: 550–556.
2. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014; 134: 1527–1534.
3. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci 2006; 7: 535–547.
4. Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007; 87: 291–294.
5. Ständer S, Darsow U, Mettang T, Gieler U, Maurer M, Ständer H, et al. S2k guideline – Chronic Pruritus. J Dtsch Dermatol Ges 2012; 10: S1–27.
6. Carr CW, Veledar E, Chen SC. Factors mediating the impact of chronic pruritus on quality of life. JAMA Dermatol 2014; 150: 613–620.
7. Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med 2013; 368: 1625–1634.
8. Ständer S, Augustin M, Reich A, Blome C, Ebata T, Phan NQ, et al. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. Acta Derm Venereol 2013; 93: 509–514.
9. Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Ständer S. Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol 2006; 31: 762–767.
10. Fett N, Haynes K, Propert KJ, Margolis DJ. Five-year malignancy incidence in patients with chronic pruritus: a populationbased cohort study aimed at limiting unnecessary screening practices. J Am Acad Dermatol 2014; 70: 651–658.
11. Matterne U, Apfelbacher CJ, Vogelgsang L, Loerbroks A, Weisshaar E. Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol 2013; 93: 532–537.
12. Bathe A, Weisshaar E, Matterne U. Chronic pruritus – more than a symptom: a qualitative investigation into patients’ subjective illness perceptions. J Adv Nurs 2013; 69: 316–326.
13. Ständer S, Blome C, Breil B, Bruland P, Darsow U, Dugas M, et al. Erfassung von Pruritus – aktuelle Standards und Implikationen für die Praxis. Hautarzt 2012; 63: 521–531.
14. Fritz F, Balhorn S, Riek M, Breil B, Dugas M. Qualitative and quantitative evaluation of EHR-integrated mobile patient questionnaires regarding usability and cost-efficiency. Int J Med Inform 2012; 81: 303–313.
15. Dziuballe P, Forster C, Breil B, Thiemann V, Fritz F, Lechtenbörger J, et al. The single source architecture x4T to connect medical documentation and clinical research. Stud Health Technol Inform 2011; 169: 902–906.
16. Ständer S, Stumpf A, Osada N, Wilp S, Chatzigeorgakidis E, Pfleiderer B. Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol 2013; 168: 1273–1280.
17. Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther 2010; 23: 590–596.
18. Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, Mettang T, et al. European guideline on chronic pruritus. Acta Derm Venereol 2012; 92: 563–581.
19. Stumpf A, Ständer S. Neuropathic itch: diagnosis and management. Dermatol Ther 2013; 26: 104–109.
20. Savk E, Savk O, Bolukbasi O, Culhaci N, Dikicioğlu E, Karaman G, et al. Notalgia paresthetica: a study on pathogenesis. Int J Dermatol 2000; 39: 754–759.
21. Savk O, Savk E. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol 2005; 52: 1085–1087.
22. Goodkin R, Wingard E, Bernhard JD. Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic [corrected] pruritus. J Am Acad Dermatol 2003; 48: 521–524.
23. Marziniak M, Phan NQ, Raap U, Siepmann D, Schürmeyer- Horst F, Pogatzki-Zahn E, et al. Brachioradial pruritus as a result of cervical spine pathology: the results of a magnetic resonance tomography study. J Am Acad Dermatol 2011; 65: 756–762.
24. Kwatra SG, Ständer S, Bernhard JD, Weisshaar E, Yosipovitch G. Brachioradial pruritus: a trigger for generalization of itch. J Am Acad Dermatol 2013; 68: 870–873.
25. Fritz F, Phan NQ, Dugas M, Augustin M, Ständer S. Correlation of itch intensity with quality of life, anxiety and depression. Acta Derm Venereol 2011; 91: 636–637.
26. WHO Gender and Health. Technical Paper 1998. Available at: http://www.who.int/healthsystems/topics/delivery/technical_brief_ehp.pdf?ua=1 [Accessed 2014 Jun 30].
27. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet 2008; 9: 911–922.
28. Stumpf A, Burgmer M, Schneider G, Heuft G, Schmelz M, Phan NQ, et al. Sex differences in itch perception and modulation by distraction – an fMRI pilot study in healthy volunteers. Plos One 2013; 8:e79123.
29. Niemeier V, Kupfer J, Gieler U. Observations during an itch-inducing lecture. Dermatol Psychosom 1991; 1: 15–19.
30. Niemeier V, Kupfer J, Al-Abesie S, Schill WB, Gieler U. Hauterkrankungen zwischen psychoneuroimmunologischer Forschung und psychosomatischer Therapie. Z Dermatol 1999; 185: 62–66.
31. Dark K, Peeke HVS, Ellman G, Salfi M. Behaviorally conditioned histamine release. Prior stress and the conditionability and extinction of the response. Ann N Y Acad Sci 1987; 496: 578–582.
32. Scholz OB, Hermanns N. Krankheitsverhalten und Kognitionen beeinflussen die Juckreiz-Wahrnehmung von Patienten mit atopischer Dermatitis. Z Klin Psychol 1994; 23: 127–135.
33. Fostini AC, Girolomoni G, Tessari G. Prurigo nodularis: an update on etiopathogenesis and therapy. J Dermatolog Treat 2013; 24: 458–462.
34. Leibovici V, Magora F, Cohen S, Ingber A. Effects of virtual reality immersion and audiovisual distraction techniques for patients with pruritus. Pain Res Manag 2009; 14: 283–286.
35. Yosipovitch G, Ishiuji Y, Patel TS, Hicks MI, Oshiro Y, Kraft RA, et al. The brain processing of scratching. J Invest Dermatol 2008; 128: 1806–1811.
36. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005; 9: 463–484.
37. Mochizuki H, Sadato N, Saito DN, Toyoda H, Tashiro M, Okamura N, et al. Neural correlates of perceptual difference between itching and pain: a human fMRI study. Neuroimage 2007; 36: 706–717.
38. Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K. Imaging of central itch modulation in the human brain using positron emission tomography. Pain 2003; 105: 339–346.
39. Valet M, Sprenger T, Boecker H, Willoch F, Rummeny E, Conrad B, et al. Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain – an fMRI analysis. Pain 2004; 109: 399–408.
40. Tracey I, Ploghaus A, Gati JS, Clare S, Smith S, Menon RS, et al. Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 2002; 22: 2748–2752.
41. Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron 2007; 55: 377–391.
42. Akiyama T, Carstens E. Neural processing of itch. Neuroscience 2013; 250: 697–714.
43. Bautista DM, Wilson SR, Hoon MA. Why we scratch an itch: the molecules, cells and circuits of itch. Nat Neurosci 2014; 17: 175–182.
44. Ständer S, Schmelz M. Chronic itch and pain – similarities and differences. Eur J Pain 2006; 10: 473–478.
45. Ringkamp M, Schepers RJ, Shimada SG, Johanek LM, Hartke TV, Borzan J, et al. A role for nociceptive, myelinated nerve fibers in itch sensation. J Neurosci 2011; 31: 14841–14849.
46. Han L, Ma C, Liu Q, Weng HJ, Cui Y, Tang Z, et al. A subpopulation of nociceptors specifically linked to itch. Nat Neurosci 2013; 16: 174–182.
47. Maier C, Baron R, Tölle TR, Binder A, Birbaumer N, Birklein F, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010; 150: 439–450.
48. Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013; 154: 1807–1819.
49. Baron R, Tölle TR, Gockel U, Brosz M, Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain 2009; 146: 34–40.
50. Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006; 123: 231–243.
51. Bernhard JD, Bordeaux JS. Medical pearl: the ice-pack sign in brachioradial pruritus. J Am Acad Dermatol 2005; 52: 1073.
52. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, et al. Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17: 903–912.
53. Schuhknecht B, Marziniak M, Wissel A, Phan NQ, Pappai D, Dangelmaier J, et al. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy. Br J Dermatol 2011; 165: 85–91.
54. Haas S, Capellino S, Phan NQ, Böhm M, Luger TA, Straub RH, et al. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis. J Dermatol Sci 2010; 58: 193–197.
55. Schmelz M, Hilliges M, Schmidt R, Ørstavik K, Vahlquist C, Weidner C, et al. Active “itch fibers” in chronic pruritus. Neurology 2003; 61: 564–566.
56. Ständer S, Moormann C, Schumacher M, Buddenkotte J, Artuc M, Shpacovitch V, et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 2004; 13: 129–139.
57. Ständer S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001; 44: 471–478.
58. Ständer S, Luger T. NK-1 antagonists and itch. In: Cowan A, editor. Pharmacology of itch. Heidelberg: Springer; 2014 (in press)
59. Ständer S, Siepmann D, Herrgott I, Sunderkötter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One 2010; 5: 10968.
60. Siepmann D, Weishaupt C, Luger TA, Ständer S. Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients. Dermatology 2011; 223: 374–380.